Calidad de vida relacionada con la salud en pacientes con diferentes formas clínicas de COVID-19, Sonora, México.
Calidad de vida relacionada con la salud y COVID-19
DOI:
https://doi.org/10.18633/biotecnia.v25i3.2076Palabras clave:
COVID-19, Calidad de vida relacionada con la salud, severidad, MéxicoResumen
Antecedentes. La concurrencia de COVID-19 y padecimientos crónicos no transmisibles son capaces de deteriorar la calidad de vida relacionada con la salud (CVRS) de las personas, pero poco se ha investigado al respecto en México. Objetivo. Examinar la CVRS de pacientes recuperados de COVID-19, estratificados por su severidad clínica. Material y métodos. Encuesta transversal en 144 adultos mayores de 18 años, con diagnóstico confirmado de infección por SARS-CoV-2 en localidades de Sonora. La CVRS fue examinada mediante el cuestionario SF-36 y comparada de acuerdo con la gravedad de las manifestaciones clínicas. Resultados. 131 sujetos se clasificaron con COVID-19 no grave y 13 con un cuadro grave. La media global (76.4± 18.4) de la CVRS no fue estadísticamente diferente entre los pacientes agrupados por su severidad clínica; sin embargo, los pacientes con una comorbilidad tuvieron la menor puntuación (72.00 ± 20.74), especialmente los que padecen DT2 (66.33 ± 23.75). También hubo menores puntajes en la función física (58.8± 29.6) y el dolor corporal (69.8±20.2). Conclusiones. No se observó una diferencia significativa en la CVRS de pacientes de acuerdo con la severidad de las manifestaciones clínicas de COVID-19.
Descargas
Citas
Alonso J., Prieto L., Antó J.M. 1995. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Medicina Clinica. 1995;104(20):771–6. https://europepmc.org/article/med/7783470
Anastasio F., Barbuto S., Scarnecchia E., Cosma P., Fugagnoli A., Rossi G., et al. 2021. Medium-term impact of COVID-19 on pulmonary function, functional capacity, and quality of life. European Respir-atory Journal. 58(3): 2004015. doi:10.1183/13993003.04015-2020
Ayuso García B., Pérez López A., Besteiro Balado Y., Romay Lema E., García País M.J., Marchán-López A., et al. 2022. Calidad de vida relacionada con la salud en pacientes recuperados de COVID-19. Journal of Healthcare Quality Research. 37(4): 208-125. doi:10.1016/j.jhqr.2022.01.001
Ceban F., Leber A., Jawad M.Y., Yu M., Lui L.M.W., Subramaniapillai M., et al. 2022. Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research. In-fectious Diseases. 54 (7): 467–77. https://doi.org/10.1080/23744235.2022.2043560
Chen K.Y., Li T., Gong F., Zhang J.S., Li X.K. 2020. Predictors of health-related quality of life and in-fluencing factors for COVID-19 patients, a follow-up at one month. Frontiers Psychiatry. 11:668 https://doi.org/10.3389/fpsyt.2020.00668
Consejo Nacional de Ciencia y Tecnología. COVID - 19 Tablero México. 2022. Consultado 23 Ene 2023. Disponible en https://datos.covid-19.conacyt.mx/
Crook H., Raza S., Nowell J., Young M., Edison P. 2021. Long covid-mechanisms, risk factors, and management. British Medical Journal. 374: n1648. https://doi.org/10.1136/bmj.n1648
Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re’em Y., et al. 2021. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. E Clinical Medicine. 38(101019):101019. https://doi.org/10.1016/j.eclinm.2021.101019
Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., et al. 2022. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 604 (7907): 697–707. https://doi.org/10.1038/s41586-022-04569-5
Garrigues E., Janvier P., Kherabi Y., LeBout A., Hamon A., Gouze H., et al. 2020. Post-discharge per-sistent symptoms and health-related quality of life after hospitalization for COVID-19. Journal of Infec-tion. 81, e4-e6 https://doi.org/10.1016/j.jinf.2020.08.29
Hanson S.W., Abbafati C., Aerts J.G., Al-Aly Z., Ashbaugh C., Ballouz T., et al. 2022. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. Journal of the American Medical Association. 328 (16): 1604–15. http://dx.doi.org/10.1001/jama.2022.18931
Groff D., Sun A., Sentongo A.E., Ba D.M., Parsons N., Poudel G.R., et al. 2021. Short-term and long-term rates of post-acute sequelae of SARS-CoV-2 infection: A systematic review. JAMA Network Open. 4 (10): e2128568. doi:10.1001/jamanetworkopen.2021.28568
Guo L., Lin J., Ying W., Zheng C., Tao L., Ying B., et al. 2020. Correlation study of short-term mental health in patients discharged after coronavirus disease 2019 (COVID-19) infection without comorbidities: a prospective study. Neuropsychiatric Diseases Treatment. 16: 2661. doi:10.2147/NDT.S278245
Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. 2021. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 397: 220-32. https://doi.org/10.1016/S0140-6736(20)32656-8
Liu K., Zhang W., Yang Y., Zhang J., Li Y., Chen Y. 2020. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complementary Therapies in Clinical Practice. 39 (101166):101166 https://doi.org/10.1016/j.ctcp.2020.101166
Lizán-Tudela L. 2009. La calidad de vida relacionada con la salud. Atención Primaria. 41 (7): 411–6. doi:10.1016/j.aprim.2008.10.019
Long E., Patterson S., Maxwell K., Blake C., Bosó-Pérez R., Lewis R., et al. 2022. COVID-19 pandemic and its impact on social relationships and health. Journal of Epidemiology and Community Health. 76 (2): 128-132. https://doi.org/10.1136/jech-2021-216690
Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., et al. 2021. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Scientific Reports. 11(1):16144 https://doi.org/10.1038/s41598-021-95565-8
López-Sampalo A., Bernal-López M.R., Gómez-Huelgas R. 2022. Síndrome de COVID-19 persistente. Una revisión narrativa. Revista Clínica Española. 2022; 222(4):241-250. https://doi.org/10.1016/j.rce.2021.10.003.
Mehandru S., Merad M. 2022. Pathological sequelae of long-haul COVID. Nature Immunology. 23 (2): 194–202. https://doi.org/10.1038/s41590-021-01104-y
Mehta O.P., Bhandari P., Raut A., Kacimi S.E.O., Huy N.T. 2020. Coronavirus Disease (COVID-19): Comprehensive review of clinical presentation. Frontiers in Public Health. 8:582932 https://doi.org/10.3389/fpubh.2020.582932
Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., et al. 2021. Post-acute COVID-19 syndrome. Nature Medicine. 27(4):601–15. doi.org/10.1038/s41591-021-01283-z
Nguyen H.C., Nguyen M.H., Do B.N., Tran C.Q., Nguyen T.T., Pham K.M., et al. 2022. People with suspected COVID-19 symptoms were more likely depressed and had lower health-related quality of life: The potential benefit of health literacy. Journal of Clinical Medicine. 9 (4): 965. https://doi.org/10.3390/jcm9040965
Poudel A.N., Zhu S., Cooper N., Roderick P., Alwan N., Tarrant C., et al. 2021. Impact of Covid-19 on health-related quality of life of patients: A structured review. PLoS One. 16(10):e0259164. doi:10.1371/journal.pone.0259164
Premraj L., Kannapadi N., Briggs J., Seal S., Battaglini D., Fanning J., et al. Mid and long-term neuro-logical and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. Journal of Neurological Sciences. 434(120162):120162
Sanchez-Ramirez D., Normand K., Yang Z., Torres R. 2021. Long-Term impact of COVID-19: a sys-tematic Review of the literature and meta-analysis. Biomedicines. 9: 900. https://doi.org/10.3390/biomedicines9080900
Van den Borst B., Peters J.B., Brink M., Schoon Y., Bleeker-Rovers C.P., Schers H., et al. 2021. Com-prehensive health assessment three months after recovery from acute COVID-19. Clinical Infectious Diseases. 73(5):e1089–98 doi:10.1093/cid/ciaa1750
Vilagut G., Ferrer M., Rajmil L., Rebollo P., Permanyer-Miralda G., Quintana J.M. et al. 2005. El cues-tionario de salud SF-36 español: una década de experiencia y nuevos desarrollos. Gaceta Sanitaria. 19 (2): 135-50. https://scielo.isciii.es/pdf/gs/v19n2/revision1.pdf
Ware J.E., Sherbourne C.D. 1992. The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Medical Care. 30(6): 473–83. http://www.jstor.org/stable/3765916
Ware J.E. 2000. SF-36 Health Survey Update. Spine. 25 (24): 31303139. https://journals.lww.com/spinejournal/Citation/2000/12150/SF_36_Health_Survey_Update.8.aspx
World Health Organization (WHO). 2021. Living guidance for clinical management of COVID-19. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2
World Health Organization. WHO Coronavirus (COVID-19) dashboard. 2023. https://covid19.who.int
Archivos adicionales
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
La revista Biotecnia se encuentra bajo la licencia Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
_(2).jpg)
